The AML and AMH groups demonstrated a significantly higher phosphorylated AKT/total AKT ratio compared with the A and M groups, suggesting a synergistic enhancement in the Akt-mediated protein synthesis pathway. The gene discussed is AKT1; the disease is acute myeloid leukemia.